Purchase Order 75N95024P00390
- Not listed
- This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development, a civilian agency under the U.S. Department of Health and Human Services, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $3,673.00 award is for a service plan for a SpectraMax M5 spectrophotometer system used for bioanalytical measurement and life sciences research. The performance period is from November 1, 2013, to October 31, 2014. No set-aside was used for...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services (HHS), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for a one-year maintenance agreement for a SpectraMax M5 multiplate reader, a specialized laboratory instrument used in life sciences research and drug discovery. The award has a ceiling value of $10,237.00 and does not...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to Molecular Devices LLC, a division of Danaher Corporation, for a SERVICE PLAN FOR SPECTRAMAX M5 instrument. The contract has a ceiling value of $5,947.00 and a completion date of March 30, 2013. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $7,332.00, is for a service plan for a SpectraMax M5 microplate reader system. This award does not have a set-aside designation. Molecular Devices LLC is a leading provider of bioanalytical measurement...
- This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $10,217.00 contract is for a maintenance agreement covering Molecular Devices' specialized bioanalytical instrumentation, software, and related services used in life sciences research, pharmaceutical development, and public health initiatives. As the original equipment manufacturer, Molecular...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Molecular Devices LLC, a division of Danaher Corporation, for preventive maintenance services on SpectraMax L and StakMax laboratory instruments. The $22,236.00 contract does not have a set-aside designation and was awarded on April 26, 2019 with a completion date of June 28, 2020. Molecular Devices...
- This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $243,974.00, is for extended warranty and preventative maintenance services on an existing ImageXpress Micro Confocal instrument used by NCATS for high-throughput microplate-based automated imaging of...
- This is a $10,313 firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Molecular Devices LLC, a division of Danaher Corporation, for service on a SpectraMax L instrument. The contract does not have a set-aside designation. Molecular Devices is a leading provider of bioanalytical measurement solutions for life sciences research, pharmaceutical development, and...
- This is a firm-fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for a service maintenance plan for a SpectraMax M3 Multimode Reader. The contract has a ceiling value of $54,173.00 and a completion date of August 7, 2025. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contract awards from agencies...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Molecular Devices LLC, a division of Danaher Corporation. The $24,732.09 contract is for the company's specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. As the original equipment manufacturer, Molecular Devices often receives...
This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Molecular Devices LLC, a division of Danaher Corporation. The $75,324.00 contract is for a 4-year service and maintenance agreement for the SpectraMax M5 System, a specialized laboratory instrument used in life sciences research and drug discovery. This non-set-aside award leverages Molecular Devices' expertise as the original equipment manufacturer to provide preventative maintenance, on-site performance assurance, and repair services for the SpectraMax M5 System, which supports NCATS' mission to accelerate the development and delivery of new treatments and diagnostics. Molecular Devices has a strong track record of federal contract awards from agencies like NIH, VA, USDA, FDA, and EPA for a range of its bioanalytical measurement solutions and related services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 7/18/24 |